FDA Clearance Tracker · P180050
BAROSTIM NEO® System
Last checked: Nov 20, 2026Latest source record: Aug 16, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Aug 16, 2019
Approved
Time to decision
239 days
Received Dec 20, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P180050
- Device name
- BAROSTIM NEO® System
- Applicant
- Cvrx, Inc.
- Applicant location
- Minneapolis, MN
- Received
- Dec 20, 2018
- Decided
- Aug 16, 2019
- Decision
- Approved
- Supplements
- 15 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Stimulator, carotid sinus nerve (DSR)
- Device class
- Class III
- Regulation
- 21 CFR 870.3850
FDA's approval statement
As written in FDA's record.
Approval for The BAROSTIM NEO System. The device is indicated for the improvement of symptoms of heart failure. quality of life, six-minute hall walk and functional status, for patients who remain symptomatic despite treatment with guideline-directed medical therapy, are NYHA Class III or Class II (who had a recent history of Class III), have a left ventricular ejection fraction <= 35%, a NT-proBNP < 1600 pg/ml and excluding patients indicated for Cardiac Resynchronization Therapy (CRT) according to AHA/ACC/ESC guidelines.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code DSR (Stimulator, carotid sinus nerve).
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
Other decisions for Cvrx, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.